[go: up one dir, main page]

HU913648D0 - Enhanced method for explication of polypeptides - Google Patents

Enhanced method for explication of polypeptides

Info

Publication number
HU913648D0
HU913648D0 HU364891A HU364891A HU913648D0 HU 913648 D0 HU913648 D0 HU 913648D0 HU 364891 A HU364891 A HU 364891A HU 364891 A HU364891 A HU 364891A HU 913648 D0 HU913648 D0 HU 913648D0
Authority
HU
Hungary
Prior art keywords
explication
polypeptides
enhanced method
enhanced
Prior art date
Application number
HU364891A
Other languages
Hungarian (hu)
Other versions
HUT60523A (en
Inventor
Harry Meade
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of HU913648D0 publication Critical patent/HU913648D0/en
Publication of HUT60523A publication Critical patent/HUT60523A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HU364891A 1990-02-22 1991-02-22 Improved process for expressing polypeptides HUT60523A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48345090A 1990-02-22 1990-02-22

Publications (2)

Publication Number Publication Date
HU913648D0 true HU913648D0 (en) 1992-07-28
HUT60523A HUT60523A (en) 1992-09-28

Family

ID=23920077

Family Applications (1)

Application Number Title Priority Date Filing Date
HU364891A HUT60523A (en) 1990-02-22 1991-02-22 Improved process for expressing polypeptides

Country Status (7)

Country Link
EP (1) EP0471832A1 (en)
JP (1) JPH04505710A (en)
AU (1) AU652355B2 (en)
CA (1) CA2055500A1 (en)
FI (1) FI914947A0 (en)
HU (1) HUT60523A (en)
WO (1) WO1991013151A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048729A (en) * 1987-05-01 2000-04-11 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
GB9027917D0 (en) * 1990-12-21 1991-02-13 Ici Plc Expression systems
GB9028062D0 (en) * 1990-12-24 1991-02-13 Agricultural & Food Res Production of transgenic animals
US5714345A (en) * 1990-12-24 1998-02-03 Pharmaceutical Proteins Limited Increased expression of a gene by a second transferred mammary gland specific sequence transgenic
US6054288A (en) * 1991-11-05 2000-04-25 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
NZ245015A (en) 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US5968502A (en) * 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6063630A (en) * 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
US6692737B1 (en) 1991-11-05 2004-02-17 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5298422A (en) * 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US6531124B1 (en) 1992-07-10 2003-03-11 Transkaryotic Therapies, Inc. In vivo production and delivery of insulinotropin for gene therapy
US6670178B1 (en) 1992-07-10 2003-12-30 Transkaryotic Therapies, Inc. In Vivo production and delivery of insulinotropin for gene therapy
US5959171A (en) * 1994-08-17 1999-09-28 Pharming B.V. Method for the production of biologically active polypeptides in a mammal's
JP3240370B2 (en) * 1997-01-17 2001-12-17 農林水産省畜産試験場長 Method for introducing foreign gene into cultured cells or fertilized eggs
GB9718908D0 (en) 1997-09-05 1997-11-12 Rowett Research Services Limit Proteins
GB0314856D0 (en) 2003-06-25 2003-07-30 Unitargeting Res As Protein expression system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
AU622870B2 (en) * 1987-08-07 1992-04-30 Medical Research Council, The Vector for integration site independent gene expression in mammalian host cells
GB8718779D0 (en) * 1987-08-07 1987-09-16 Grosveld F G Dna sequence & expression vector

Also Published As

Publication number Publication date
FI914947A0 (en) 1991-10-21
AU7486391A (en) 1991-09-18
WO1991013151A1 (en) 1991-09-05
CA2055500A1 (en) 1991-08-23
JPH04505710A (en) 1992-10-08
EP0471832A1 (en) 1992-02-26
HUT60523A (en) 1992-09-28
AU652355B2 (en) 1994-08-25

Similar Documents

Publication Publication Date Title
GB2252975B (en) Method of making organopolysiloxanes
EP0545718A3 (en) Method of making bone-implants
HU913648D0 (en) Enhanced method for explication of polypeptides
PL291886A1 (en) Method of obtaining derivatives of 2-aminopyrimidylocarbonamide-4
EP0452959A3 (en) Method of application
PL288761A1 (en) Method of obtaining novel polypeptides
PL291562A1 (en) Method of obtaining novel heterodiazepins
PL290856A1 (en) Method of obtaining Ÿ-lactames
PL292087A1 (en) Method of obtaining derivatives of 8-chloroquinolone
PL288627A1 (en) Method of obtaining pentafluorodichloropropanes
GB9021368D0 (en) Method of manufacture
PL283907A1 (en) Method of obtaining oligoestrols
GB9020172D0 (en) Method of aligning components
GB2241919B (en) Method of manufacture
PL292308A1 (en) Method of obtaining tioxane
PL287126A1 (en) Method of obtaining pululane
PL292497A1 (en) Method of obtaining novel 3h-purines
GB9111703D0 (en) Method of transsilylation
RU1769863C (en) Method for application of choledochoduodenostomy
PL285570A1 (en) Method of obtaining n-2-minoethyl-3-aminopropyltrimethoxysilane
RU1815115C (en) Method of placing angular measures
GB9012717D0 (en) Method of transsilylation
PL284887A2 (en) Method of obtainining thymoguinone
GB9016078D0 (en) Method of manufacture
GB9022886D0 (en) Method of manufacture

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: GENE PHARMING EUROPE, NL

DFD9 Temporary prot. cancelled due to non-payment of fee